Mark Clendenning

9.6k citations

63 papers · 2.9k · 1 hit paper · h-index 25

Impact in

Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer
Cancer Research top 1%
- Cancer Genomics and Diagnostics

Papers in

Pathology and Forensic Medicine 50
- Genetic factors in colorectal cancer 50
Oncology 39
- Colorectal Cancer Screening and Detection 32
- Colorectal Cancer Treatments and Studies 12

Co-authors: Daniel D. Buchanan (46 shared papers)Mark A. Jenkins (42 shared papers)John L. Hopper (33 shared papers)Christophe Rosty (36 shared papers)Albert de la Chapelle (9 shared papers)Heather Hampel (5 shared papers)Aung Ko Win (28 shared papers)Kaisa Sotamaa (3 shared papers)
Journals: Familial Cancer (11 papers)Human Mutation (3 papers)PLoS ONE (3 papers)Genetics in Medicine (2 papers)Modern Pathology (2 papers)
Partner nations: Australia United States Canada

In The Last Decade

Mark Clendenning

60 papers receiving 2.8k citations

Mark Clendenning's Hit Papers

align trajectories log scale

Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer 2008 · 612 citations

Peers

Countries citing papers authored by Mark Clendenning

Since Specialization

Citations

This map shows the geographic impact of Mark Clendenning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Clendenning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Clendenning more than expected).

Fields of papers citing papers by Mark Clendenning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Clendenning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Clendenning. The network helps show where Mark Clendenning may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Clendenning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Clendenning Line = papers co-authored together Mark Clendenning links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Feasibility of Screening for Lynch Syndrome Among Patients With Colorectal Cancer Journal of Clinical Oncology ·Heather Hampel, Wendy L. Frankel, Edward W. Martin, Mark Arnold, K. S. Khanduja, Philip Kuebler, Mark Clendenning, Kaisa Sotamaa, Thomas W. Prior, Judith A. Westman, Jenny Panescu, Dan Fix, Janet Lockman, Jennifer LaJeunesse, Ilene Comeras, Albert de la Chapelle Hit paper breakdown →	2008	612
2	The Clinical Phenotype of Lynch Syndrome Due to Germ-Line PMS2 Mutations Gastroenterology ·Leigha Senter, Mark Clendenning, Kaisa Sotamaa, Heather Hampel, Jane Green, John D. Potter, Annika Lindblom, Kristina Lagerstedt‐Robinson, Stephen N. Thibodeau, Noralane M. Lindor, Joanne Young, Ingrid Winship, James G. Dowty, Darren M. White, John L. Hopper, Laura Baglietto, Mark A. Jenkins, Albert de la Chapelle	2008	377
3	Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study Annals of Oncology ·Rodrigo Dienstmann, Mike J. Mason, Frank A. Sinicrope, Amanda I. Phipps, Sabine Tejpar, Arild Nesbakken, Stine A. Danielsen, Anita Sveen, Daniel D. Buchanan, Mark Clendenning, Christophe Rosty, Brian M. Bot, Steven R. Alberts, J. Milburn Jessup, Ragnhild A. Lothe, Mauro Delorenzi, Polly A. Newcomb, Daniel J. Sargent, Justin Guinney	2017	166
4	Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) Diagnostics JNCI Journal of the National Cancer Institute ·Kristina Lagerstedt‐Robinson, Thalia D. Liu, Jana Vandrovcová, B. Halvarsson, Mark Clendenning, Thierry Frébourg, Nikolaos G. Papadopoulos, K. W. Kinzler, Bert Vogelstein, Païvi Peltomäki, Richard D. Kolodner, Mef Nilbert, Annika Lindblom	2007	147
5	Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features Modern Pathology ·Christophe Rosty, Joanne Young, Michael D. Walsh, Mark Clendenning, Rhiannon Walters, Sally‐Ann Pearson, Erika Pavluk, Belinda Nagler, David Pakenas, Jeremy R. Jass, Mark A. Jenkins, Aung Ko Win, Melissa C. Southey, Susan Parry, John L. Hopper, Graham G. Giles, Elizabeth Williamson, Dallas R. English, Daniel D. Buchanan	2013	126
6	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype Modern Pathology ·Michael D. Walsh, Mark Clendenning, Elizabeth Williamson, Sally‐Ann Pearson, Rhiannon Walters, Belinda Nagler, David Packenas, Aung Ko Win, John L. Hopper, Mark A. Jenkins, Andrew Haydon, Christophe Rosty, Dallas R. English, Graham G. Giles, Michael A. McGuckin, Joanne Young, Daniel D. Buchanan	2013	122
7	PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival PLoS ONE ·Christophe Rosty, Joanne Young, Michael D. Walsh, Mark Clendenning, Kristy Sanderson, Rhiannon Walters, Susan Parry, Mark A. Jenkins, Aung Ko Win, Melissa C. Southey, John L. Hopper, Graham G. Giles, Elizabeth Williamson, Dallas R. English, Daniel D. Buchanan	2013	105
8	BRAFV600E Immunohistochemistry Facilitates Universal Screening of Colorectal Cancers for Lynch Syndrome The American Journal of Surgical Pathology ·Christopher W. Toon, Michael D. Walsh, Angela Chou, David Capper, Adele Clarkson, Loretta Sioson, Stephen Clarke, Scott Mead, Rhiannon Walters, Mark Clendenning, Christophe Rosty, Joanne Young, Aung Ko Win, John L. Hopper, Ashley Crook, Andreas von Deimling, Mark A. Jenkins, Daniel D. Buchanan, Anthony J. Gill	2013	104
9	Long-range PCR facilitates the identification ofPMS2-specific mutations Human Mutation ·Mark Clendenning, Heather Hampel, Jennifer LaJeunesse, Annika Lindblom, Jan Lockman, Mef Nilbert, Leigha Senter, Kaisa Sotamaa, Albert de la Chapelle	2006	76
10	Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype International Journal of Cancer ·Harindra Jayasekara, Dallas R. English, Andrew Haydon, Allison Hodge, Brigid M. Lynch, Christophe Rosty, Elizabeth Williamson, Mark Clendenning, Melissa C. Southey, Mark A. Jenkins, Robin Room, John L. Hopper, Roger L. Milne, Daniel D. Buchanan, Graham G. Giles, Robert J. MacInnis	2017	74
11	The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease Gut ·Michael O. Woods, H. Banfield Younghusband, Patrick S. Parfrey, Steven Gallinger, J. McLaughlin, Elizabeth Dicks, Susan Stuckless, Aaron Pollett, Bharati Bapat, Miralem Mrkonjic, Albert de la Chapelle, Mark Clendenning, Stephen N. Thibodeau, Michelle Simms, A. Dohey, Phillip Williams, Desmond Robb, Caroline Searle, Jane S. Green, R. C. Green	2010	65
12	Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome) The Application of Clinical Genetics ·Aung Ko Win, Daniel D. Buchanan, Christophe Rosty, Mark Clendenning, Amanda B. Spurdle	2014	63
13	A Multifactorial Likelihood Model for MMR Gene Variant Classification Incorporating Probabilities Based on Sequence Bioinformatics and Tumor Characteristics: A Report from the Colon Cancer Family Registry Human Mutation ·Bryony A. Thompson, David E. Goldgar, Carol Paterson, Mark Clendenning, Rhiannon Walters, Sven Arnold, Michael T. Parsons, Walsh Michael D., Steven Gallinger, Robert W. Haile, John L. Hopper, Mark A. Jenkins, Loı̈c Le Marchand, Noralane M. Lindor, Polly A. Newcomb, Stephen N. Thibodeau, (unknown), Joanne Young, Daniel D. Buchanan, Sean V. Tavtigian, Amanda B. Spurdle	2012	56
14	Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1 Genetics in Medicine ·Daniel D. Buchanan, Jenna R. Stewart, Mark Clendenning, Christophe Rosty, Khalid Mahmood, Bernard J. Pope, Mark A. Jenkins, John L. Hopper, Melissa C. Southey, Finlay Macrae, Ingrid Winship, Aung Ko Win	2017	40
15	Should the grading of colorectal adenocarcinoma include microsatellite instability status? Human Pathology ·Christophe Rosty, Elizabeth Williamson, Mark Clendenning, Rhiannon Walters, Aung Ko Win, Mark A. Jenkins, John L. Hopper, Ingrid Winship, Melissa C. Southey, Graham G. Giles, Dallas R. English, Daniel D. Buchanan	2014	39
16	A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome Journal of Medical Genetics ·Mark Clendenning, Leigha Senter, Heather Hampel, Kristina Lagerstedt‐Robinson, Shuxin Sun, Daniel D. Buchanan, Michael D. Walsh, Mef Nilbert, J. Green, John D. Potter, Annika Lindblom, Albert de la Chapelle	2008	39
17	High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry Familial Cancer ·Christophe Rosty, Michael D. Walsh, Noralane M. Lindor, Stephen N. Thibodeau, Erin Mundt, Steven Gallinger, Melyssa Aronson, Aaron Pollett, John A. Baron, Sally‐Ann Pearson, Mark Clendenning, Rhiannon Walters, Belinda Nagler, William Crawford, Joanne Young, Ingrid Winship, Aung Ko Win, John L. Hopper, Mark A. Jenkins, Daniel D. Buchanan	2014	39
18	Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancer Epigenetics ·Rhiannon Walters, Elizabeth Williamson, Dallas R. English, Joanne Young, Christophe Rosty, Mark Clendenning, Michael D. Walsh, Susan Parry, Dennis J. Ahnen, John A. Baron, Aung Ko Win, Graham G. Giles, John L. Hopper, Mark A. Jenkins, Daniel D. Buchanan	2013	38
19	Determining the frequency of de novo germline mutations in DNA mismatch repair genes Journal of Medical Genetics ·Aung Ko Win, Mark A. Jenkins, Daniel D. Buchanan, Mark Clendenning, Joanne Young, Graham G. Giles, Jack Goldblatt, Barbara Leggett, JL Hopper, Stephen N. Thibodeau, Noralane M. Lindor	2011	37
20	Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts Journal of Gastroenterology and Hepatology ·Daniel D. Buchanan, Mark Clendenning, Christophe Rosty, Stine V Eriksen, Michael D. Walsh, Rhiannon Walters, Stephen N. Thibodeau, Jenna R. Stewart, Susan Preston, Aung Ko Win, Louisa Flander, Driss Ait Ouakrim, Finlay Macrae, Alex Boussioutas, Ingrid Winship, Graham G. Giles, John L. Hopper, Melissa C. Southey, Dallas R. English, Mark A. Jenkins, (unknown)	2016	34

About Mark Clendenning

Mark Clendenning is a scholar working on Pathology and Forensic Medicine, Oncology, Cancer Research, Molecular Biology and Genetics, having authored 63 papers that have together received 2.9k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (50 papers), Colorectal Cancer Screening and Detection (32 papers), Cancer Genomics and Diagnostics (26 papers), Colorectal Cancer Treatments and Studies (12 papers), DNA Repair Mechanisms (6 papers), BRCA gene mutations in cancer (5 papers), Epigenetics and DNA Methylation (4 papers) and Gastric Cancer Management and Outcomes (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.1k citations), Cancer Research (1.1k citations), Oncology (1.8k citations), Genetics (412 citations) and Surgery (419 citations). Mark Clendenning has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Daniel D. Buchanan, Mark A. Jenkins, John L. Hopper, Christophe Rosty, Albert de la Chapelle, Heather Hampel, Aung Ko Win, Kaisa Sotamaa, Joanne Young and Graham G. Giles. Their work appears in journals such as Familial Cancer, Human Mutation, PLoS ONE, Genetics in Medicine and Modern Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mark Clendenning

Impact in

Papers in i

In The Last Decade

Mark Clendenning

Mark Clendenning's Hit Papers

Peers

Countries citing papers authored by Mark Clendenning

Fields of papers citing papers by Mark Clendenning

All Works

About Mark Clendenning

Explore authors with similar magnitude of impact

Papers in